← Open Payments lookup

RYAN MISCHEL: Open Payments

NPI 1174149959 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,697 in 84 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $430 · 2025 $1,697

Food & beverage: $1,697
CompanyPaymentsAmount
ABBVIE INC.15$378
E.R. Squibb & Sons, L.L.C.14$229
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$198
Neurocrine BioSciences, Inc.8$174
Teva Pharmaceuticals USA, Inc.10$156
Lundbeck LLC6$119
Otsuka America Pharmaceutical, Inc.5$108
Alkermes, Inc.4$84
Takeda Pharmaceuticals U.S.A., Inc.4$68
Janssen Pharmaceuticals, Inc2$63

Products named: VRAYLAR, COBENFY, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, UZEDY, REXULTI, TRINTELLIX.

Industry payments across VA — which companies pay providers there.